Broader pneumonia protection for babies? new vaccine trial shows promise
NCT ID NCT01692886
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tested a 13-valent pneumococcal vaccine (13vPnC) against the older 7-valent version in over 1,600 healthy infants in China. The goal was to see if the newer vaccine triggers a stronger immune response and is just as safe. Infants received four doses starting at 3 months old, and researchers measured antibody levels and side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 13-valent pneumococcal conjugate vaccine (13vPnC)
- What this could lead to
- If successful, this vaccine could provide broader protection against pneumococcal infections in infants, reducing the risk of serious diseases like pneumonia and meningitis.
- What could go wrong
- This trial is completed, so results are available. However, the vaccine may not be as effective in real-world settings or may cause side effects like fever or injection-site reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jiangsu Province Guanyun County Center for Disease prevention and Control
Guanyun County,, Jiangsu, 222200, China
-
Jiangsu Province Hongze County Center for Disease prevention and Control
Huaian City, Jiangsu, 223100, China
-
Jiangsu Province Huaiyin District Center for Disease prevention and Control
Huaian City,, Jiangsu, 223300, China
-
Jiangsu Province Lianshui County Center for Disease prevention and Control
Lianshui County, Jiangsu, 223400, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New vaccine V116 aims to shield vulnerable kids from pneumococcal disease
- Why vaccines may fail in older adults: new study investigates immune cell role
- New vaccine aims to shield High-Risk adults from pneumococcal disease
- Can a pneumonia vaccine protect the most vulnerable children?
- New vaccine V118C aims to shield kids from pneumococcal disease
- New vaccine aims to shield older adults from pneumonia